DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Ortataxel is an investigational drug.
There have been 4 clinical trials for Ortataxel. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2013.
The most common disease conditions in clinical trials are Kidney Neoplasms, Carcinoma, Renal Cell, and Lymphoma, Non-Hodgkin. The leading clinical trial sponsors are Theradex, Mario Negri Institute for Pharmacological Research, and Roswell Park Cancer Institute.
Recent Clinical Trials for Ortataxel
|An Efficacy Study Of Ortataxel In Recurrent Glioblastoma||Mario Negri Institute for Pharmacological Research||Phase 2|
|BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer||National Cancer Institute (NCI)||Phase 2|
|BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer||Roswell Park Cancer Institute||Phase 2|